What is Protrials?
ProTrials Research, Inc. operates as a woman-owned, full-service clinical research organization (CRO) based in the United States. The company specializes in providing comprehensive services across the pharmaceutical, biotechnology, and medical device industries. Its offerings encompass project management, clinical operations, quality assurance, and clinical data management, all designed to deliver high-quality site management and robust clinical development support. ProTrials has established expertise in critical therapeutic areas including oncology, ophthalmology, central nervous system disorders, infectious diseases, and women's health, positioning itself as a key partner for global clinical research initiatives.
How much funding has Protrials raised?
Protrials has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Protrials
PPP
Public-Private Partnership
What's next for Protrials?
The recent major strategic investment signifies a pivotal moment for Protrials, likely enabling accelerated expansion of its service offerings and market reach. This capital infusion is expected to bolster its capabilities in managing complex clinical trials, particularly in its areas of therapeutic strength. The company is poised to leverage this backing to enhance its technological infrastructure and potentially broaden its geographical footprint, further solidifying its role as a leading CRO in the competitive life sciences landscape. Future growth will likely focus on deepening client relationships and exploring new strategic partnerships.
See full Protrials company page
